Table 1.
Main groups | Variables |
---|---|
Patient characteristics | Age, menopausal status, comorbidity |
Reasons not to enter standard treatment program for primary breast cancer | Distant metastases, previous malignant disease (except cancer cutis/cancer colli uteri in situ), bilateral breast cancer, technically inoperable or not operated according to guidelines, patient preference |
Tumor characteristics | Histological diagnosis, tumor size, number of examined nodes, number of positive nodes, grade, ER status, HER-2 status |
Surgery | Type of preoperative biopsy, sentinel node biopsy, axillary dissection, lumpectomy +/− oncoplastic surgery, mastectomy +/− reconstruction |
Adjuvant therapy | Radiotherapy, chemotherapy, endocrine therapy, anti-HER-2 therapy |
Follow-up | Vital status, recurrence, contralateral breast cancer, other malignant disease |
Abbreviations: DBCG, Danish Breast Cancer Cooperative Group; ER, estrogen receptor; HER-2, human epidermal growth factor receptor 2.